Table 3 Clinical outcomes
| Â | Before propensity score matching | After propensity score matching | ||||
|---|---|---|---|---|---|---|
|  | NPR on clopidogrel (n = 1360) | HPR on clopidogrel (n = 409) | P Value | NPR on clopidogrel (n = 395) | HPR on clopidogrel (n = 395) | P Value |
Stent thrombosis | 7 (0.5) | 13 (3.2) | < 0.001 | 3 (0.8) | 13 (3.3) | 0.003 |
Definite/ probable Stent thrombosis | 4 (0.3) | 6 (1.5) | 0.003 | 2 (0.5) | 6 (1.5) | 0.110 |
All cause death | 18 (1.3) | 21 (5.1) | < 0.001 | 7 (1.8) | 21 (5.3) | < 0.001 |
 Cardiac death | 6 (0.4) | 10 (2.4) | 0.001 | 2 (0.5) | 10 (2.5) | 0.004 |
MI | 12 (0.9) | 7 (1.7) | 0.085 | 6 (1.5) | 7 (1.8) | 0.526 |
 STEMI | 4 (0.3) | 5 (1.2) | 0.015 | 2 (0.5) | 5 (1.3) | 0.215 |
 NSTEMI | 10 (0.7) | 3 (0.7) | NS | 5 (1.3) | 3 (0.8) | 0.734 |
Clinically driven TLR | 40 (2.9) | 26 (6.4) | < 0.001 | 24 (6.1) | 26 (6.6) | 0.111 |
Clinically driven TVR | 43 (3.2) | 32 (7.8) | < 0.001 | 25 (6.3) | 32 (8.1) | 0.019 |
Ischemic stroke | 7 (0.5) | 9 (2.2) | < 0.001 | 4 (1.0) | 7 (1.8) | 0.093 |
Bleeding (BARC≥2) | 36 (2.6) | 12 (2.9) | 0.754 | 11 (2.8) | 11 (2.8) | NS |
MACCE | 74 (5.4) | 64 (15.6) | < 0.001 | 37 (9.4) | 62 (15.7) | < 0.001 |